Gammaherpesvirinae

Gammaherpesvirinae
Virus classification
Group: Group I (dsDNA)
Order: Herpesvirales
Family: Herpesviridae
Subfamily: Gammaherpesvirinae
Genera

Gammaherpesvirinae is a subfamily of viruses in the order Herpesvirales, in the family Herpesviridae. Viruses in Gammaherpesvirinae are distinguished by reproducing at a more variable rate than other subfamilies of Herpesviridae. Mammals serve as natural hosts. There are currently 32 species in this subfamily, divided among 4 genera. Diseases associated with this subfamily include: HHV-4: infectious mononucleosis. HHV-8: kaposi's sarcoma.[1][2]

Introduction

Herpesviruses represent a group of double-stranded DNA viruses distributed widely within the animal kingdom. The family Herpesviridae, which contains eight viruses that infect humans, is the most extensively studied group within this order and comprises three subfamilies, namely Alphaherpesvirinae, Betaherpesvirinae and Gammaherpesvirinae. Gammaherpesviruses belong to four separate genera: the well-established genera Lymphocryptovirus and Rhadinovirus and the more recently defined genera Macavirus and Percavirus.

Gammaherpesviruses are of primary interest due to the two human viruses, EBV and KSHV and the diseases they cause.The gammaherpesviruses replicate and persist in lymphoid cells but some are capable of undergoing lytic replication in epithelial or fibroblast cells. Gammaherpesviruses may be a cause of chronic fibrotic lung diseases in humans and in animals.[3]

These viruses can be subdivided into two genera: lymphocryptoviruses (gamma-1) and rhadinoviruses (gamma-2). The lymphocryptoviruses (gamma-1) include Epstein-Barr virus (EBV) or Human herpesvirus 4, Lymphocryptovirus of rhesus monkeys and Herpesvirus papio of baboons, whereas the rhadinoviruses (gamma-2) include Herpesvirus saimiri (HVS), Kaposi's sarcoma-associated herpesvirus (KSHV) or Human herpesvirus 8, Rhesus monkey rhadinovirus (RRV), Equine herpesvirus 2 and Murid herpesvirus 68 (an important model system for the study of gammaherpesviruses with tractable genetics). The gammaherpesviruses, including HVS, EBV, KSHV, and RRV, are capable of establishing latent infection in lymphocytes.[4]

Within this genus there are a number of unclassified viruses including cynomys herpesvirus 1 (CynGHV-1)[5] Elephantid herpesvirus 3, Elephantid herpesvirus 4, Elephantid herpesvirus 5, Procavid herpesvirus 1, Trichechid herpesvirus 1[6] and Common bottlenose dolphin gammaherpesvirus 1.[7]

Taxonomy

Group: dsDNA

[2]

Structure

Viruses in Gammaherpesvirinae are enveloped, with icosahedral, spherical to pleomorphic, and round geometries, and T=16 symmetry. The diameter is around 150-200 nm. Genomes are linear and non-segmented, around 180kb in length.[1]

Genus Structure Symmetry Capsid Genomic arrangement Genomic segmentation
MacavirusSpherical PleomorphicT=16EnvelopedLinearMonopartite
PercavirusSpherical PleomorphicT=16EnvelopedLinearMonopartite
LymphocryptovirusSpherical PleomorphicT=16EnvelopedLinearMonopartite
RhadinovirusSpherical PleomorphicT=16EnvelopedLinearMonopartite

Virus Life cycle

The main stages in the lifecycle of Gamma herpes virus are namely
• Virus attachment and entry
• Viral DNA injection through nuclear pore complex (NPC) into nucleus
• Assembly of nucleocapsids and encapsidation of viral genome
• Primary envelopment, invaginations of nuclear membrane(s) and nuclear egress
• Tegumentation and secondary envelopment in the cytoplasm
• Egress and extracellularvirions release [8]

Genus Host details Tissue tropism Entry details Release details Replication site Assembly site Transmission
MacavirusMammalsT-lymphocytesGlycoprotiensBuddingNucleusNucleusNasal and ocular secretion
PercavirusMammalsB-lymphocytesGlycoprotiensBuddingNucleusNucleusSex; saliva
LymphocryptovirusHumans; mammalsB-lymphocytesGlycoprotiensBuddingNucleusNucleusSaliva
RhadinovirusHumans; mammalsB-lymphocytesGlycoprotiensBuddingNucleusNucleusSex; saliva

Lytic Cycle

The lytic cycle of the gammaherpesviruses is initiated only on rare occasions (Oehmig et al., 2004). Therefore, the least contribution to pathogenicity has to be expected from this stage. The ORFs expressed during that stage are further divided into immediate-early, early, and late. Promoter activation mediated by these proteins has also a strong effect on DNA synthesis from the origins of lytic DNA replication. As a result, virions are generated and released from the productively infected cells.[9]

Growth De-regulating genes of Gammaherpesvirus

Herpesviruses have large genomes containing a wide array of genes. Although the first ORF in these gammaherpesviruses have oncogenic potential, other viral genes may also play a role in viral transformation. A striking feature of the four gammaherpesviruses is that they contain distinct ORFs involved in lymphocyte signaling events. At the left end of each viral genome are located ORFs encoding distinct transforming proteins.The Gammaherpes viral genes are capable of modulating cellular signals such that cell proliferation and viral replication occur at the appropriate times in the viral life cycle.[4]

Immune evasion strategies

Viruses that establish lifelong latent infections must ensure that the viral genome is maintained within the latently infected cell throughout the life of the host, yet at the same time must also be capable of avoiding elimination by the immune surveillance system especially must avoid being detected by host CD8+ cytotoxic T lymphocytes (CTLs). The gamma-herpesviruses are characteristically latent in lymphocytes and drive the proliferation that requires the expression of latent viral antigens.[10] The majority of gammaherpesviruses encode a specific protein that is critical for maintenance of the viral genome within latently infected cells termed the genome maintenance protein (GMP). GMPs are DNA-binding proteins that ensures that, as the host cell progresses through mitosis, the viral episomes are partitioned to daughter cells. This provides continuous existence of the viral genome within the host cells.[4]

Vaccines

Attenuated virus mutants represent a promising approach towards gamma-herpesvirus infection control. Surprisingly, latency-deficient and, therefore, apathogenic MHV-68 mutants are found to be highly effective vaccines against these viruses.[10] Research in this area is almost exclusively performed using MHV68 as KSHV and EBV (the major human pathogens of this family) do not productively infect model organisms typically used for this type of experimentation.

References

  1. 1 2 "Viral Zone". ExPASy. Retrieved 15 June 2015.
  2. 1 2 ICTV. "Virus Taxonomy: 2014 Release". Retrieved 15 June 2015.
  3. ↑ Williams, KJ (March 2014). "Gammaherpesviruses and Pulmonary Fibrosis: Evidence From Humans, Horses, and Rodents". Veterinary Pathology. 51 (2): 372–384. PMID 24569614. doi:10.1177/0300985814521838.
  4. 1 2 3 Blake, N. (2010). "Immune evasion by gammaherpesvirus genome maintenance proteins". Journal of General Virology. 91 (4): 829–846. PMID 20089802. doi:10.1099/vir.0.018242-0.
  5. ↑ Nagamine B, Jones L, Tellgren-Roth C, Cavender J, Bratanich AC (2011) A novel gammaherpesvirus isolated from a black-tailed prairie dog (Cynomys ludovicianus). Arch Virol
  6. ↑ Wellehan JF, Johnson AJ, Childress AL, Harr KE, Isaza R (2008) Six novel gammaherpesviruses of Afrotheria provide insight into the early divergence of the Gammaherpesvirinae. Vet Microbiol 127(3-4):249-257
  7. ↑ Davison AJ, Subramaniam K, Kerr K, Jacob JM, Landrau-Giovannetti N, Walsh MT, Wells RS, Waltzek TB (2017) Genome sequence of a gammaherpesvirus from a common bottlenose dolphin (Tursiops truncatus). Genome Announc 5(31)
  8. ↑ Peng, L.; Ryazantsev, S.; Sun, R.; Zhou, Z. H. (2010). "Three-Dimensional Visualization of Gammaherpesvirus Life Cycle in Host Cells by Electron Tomography". Structure. 18 (1): 47–58. PMC 2866045 Freely accessible. PMID 20152152. doi:10.1016/j.str.2009.10.017.
  9. ↑ Ackermann, M. (2006). "Pathogenesis of gammaherpesvirus infections". Veterinary Microbiology. 113 (3–4): 211–222. PMID 16332416. doi:10.1016/j.vetmic.2005.11.008.
  10. 1 2 Stevenson, P. G. (2004). "Immune evasion by gamma-herpesviruses". Current Opinion in Immunology. 16 (4): 456–462. PMID 15245739. doi:10.1016/j.coi.2004.05.002.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.